Rankings
▼
Calendar
VCEL FY 2020 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$124M
+5.4% YoY
Gross Profit
$84M
67.8% margin
Operating Income
$2M
1.9% margin
Net Income
$3M
2.3% margin
EPS (Diluted)
$0.06
Cash Flow
Operating Cash Flow
$18M
Free Cash Flow
$15M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$206M
Total Liabilities
$71M
Stockholders' Equity
$134M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$124M
$118M
+5.4%
Gross Profit
$84M
$80M
+4.9%
Operating Income
$2M
-$11M
+121.1%
Net Income
$3M
-$10M
+129.6%
← Q4 2019
All Quarters
Q1 2020 →